Allostery Investments’s Zura Bio ZURA Stock Holding History

Allostery Investments’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100,000	Closed	-$250K	–	56
2024 Q4	$250K	Buy	+100,000	New	+$356K	0.26%	36

Other funds holding ZURA

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Allostery Investments's ZURA Position: Q2 2025 in Review

Allostery Investments sold out of Zura Bio (ZURA) in Q2 2025, closing a stake of 2,329,384 shares — an estimated $3M sold.

Allostery Investments first reported a position in ZURA in Q4 2024 and held it in 2 quarters. The position peaked at $3.79M in Q4 2024. 65 funds tracked by Wall St. Rank hold ZURA as of Q2 2025.

Allostery Investments reported no remaining Zura Bio position as of Q2 2025 after selling out during the quarter.
Allostery Investments sold 2,329,384 Zura Bio shares in Q2 2025, an estimated $3M.
Allostery Investments first reported a position in Zura Bio in Q4 2024 and held it in 2 quarters.
Allostery Investments's Zura Bio position peaked at $3.79M in Q4 2024.
65 funds tracked by Wall St. Rank held Zura Bio as of Q2 2025.

Based on Allostery Investments's 13F filing for Q2 2025, filed 14 Aug 2025.